Drug Safety · 2015 · 65 citations · 33 references
MedicineNeurologyPharmacologyClinical NeuroscienceClinical PharmacologyPharmacovigilanceAdverse Drug Event DetectionAdverse Drug Event ReportingClinical TrialsNeuro-oncology Clinical TrialsAdverse Neurologic EffectsFda Drug RegulationFda RegulationN-of-1 TrialsPcsk9 Gain-of-function MutationsPcsk9 Inhibitor TherapyPcsk9 InhibitorsSerious Adverse Events
33
A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia
Dirk Blom, Tomas Hala, Michael A. Bolognese et al. · New England Journal of Medicine · 2014 · 713 citations · Full text